Save time and get answers to complex questions with AI chat
How does iron rich food intake impact lipitor's efficacy?When is the expected fda decision date for apotex's ruxolitinib resubmission?Diltiazem drug class?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?Is it okay to take anti histamine when on statins?
See the DrugPatentWatch profile for synjardy
Synjardy is a brand-name medicine made of two active ingredients: empagliflozin + metformin. Based on the provided information, there’s no clear indication here that a fully approved “generic Synjardy” (a direct generic of the same combination pill) is available.
Even if there is no single generic tablet that matches Synjardy exactly, patients sometimes have alternatives such as: - Generic empagliflozin (as a standalone pill) plus - Generic metformin (as a standalone pill), Then a clinician decides whether taking the two generically can replace the branded combination.
Synjardy comes in different formulations, including Synjardy and Synjardy XR (extended release). Whether a generic is available can depend on the specific version because the extended-release formulation is harder to copy exactly than an immediate-release product.
Tell me which one you mean: 1) Synjardy (immediate-release) or 2) Synjardy XR (extended-release), and (if you know it) the dose strength (for example 5 mg/500 mg). Then I can narrow down whether an approved generic or generic-equivalent exists for that exact product.
Other Questions About Synjardy :